Evidence map›Paper›PMID 7505442›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1993

The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC'C" face of the human CD2 adhesion domain.

A R Arulanandam, J M Withka, D F Wyss, G Wagner, A Kister, P Pallai, M A Recny, E L Reinherz

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Review
  3. HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer.Journal of experimental & clinical cancer research : CR · 2024
    Article
  4. Article
  5. Article
  6. CD58 Immunobiology at a Glance.Frontiers in immunology · 2021
    Review
  7. Review
  8. Article
  9. Targeting CD83 for the treatment of graft-versus-host disease.Experimental and therapeutic medicine · 2013
    Article
  10. Article
  11. The core trisaccharide of an N-linked glycoprotein intrinsically accelerates folding and enhances stability.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. A space-time structure determination of human CD2 reveals the CD58-binding mode.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

A R ArulanandamDana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.
J M Withka
D F Wyss
G Wagner
A Kister
P Pallai
M A Recny
E L Reinherz
Harvard University · USDana-Farber Cancer Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using site-directed mutagenesis in conjunction with NMR structural data on the adhesion domain of human CD2, we have defined the binding region for CD58. Previous structural studies of rat and human CD2 indicate that this adhesion domain is immunoglobulin-like. Here we report that the CD58 binding site is a well-circumscribed, charged surface area covering approximately 770 A2 on the AGFCC'C" face of the CD2 beta barrel. This site contains beta-strand residues in the carboxyl-terminal half of the F strand (including Lys-82 and Tyr-86), the top of the C strand (Asp-32 and Lys-34), and the C' strand (Gln-46), which are all solvent exposed. In addition, several exposed residues on the FG loop (Gly-90, Lys-91, Asn-92, and Val-93), the CC' loop (Lys-41 and Lys-43), and the C'C" loop (Arg-48 and Lys-51) form this site. In contrast, neither residues on the more peripheral G and C" strands of the same CD2 surface nor residues on B, E, and D strands of the opposite face are involved in CD58 binding. This CD58 binding site is predicted to lie most distal to the T-lymphocyte surface membrane, with ready access to CD58 on the surface of the opposing antigen-presenting cell.

Indexed as

Protein Structure, SecondaryAmino Acid SequenceAnimalsAntigens, CDAntigens, Differentiation, T-LymphocyteBinding SitesCD2 AntigensCD58 AntigensCell AdhesionCell LineHumansMembrane GlycoproteinsModels, MolecularMolecular Sequence DataMutagenesis, Site-DirectedPoint MutationAntigens, CDAntigens, Differentiation, T-LymphocyteCD2 AntigensCD58 AntigensMembrane GlycoproteinsReceptors, Immunologic

Identifiers

PMID7505442
PMCPMC48034
OpenAlexW2145306211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.